Ethris signs strategic collaboration with thermo fisher scientific to provide access to mrna technology platforms

Munich--(business wire)--ethris gmbh, a clinical-stage biotechnology company pioneering next-generation rna therapeutics and vaccines, today announced a strategic collaboration with thermo fisher scientific, the world leader in serving science, to provide a fully integrated mrna solution to biopharmaceutical developers. the collaboration brings together ethris' comprehensive mrna technology platforms, including its proprietary stabilized non-immunogenic mrna (snim® rna), minimal utr and mrna ma.
TMO Ratings Summary
TMO Quant Ranking